Evidence map›Paper›PMID 27044338›Full record

ArticleDiabetologia2016

Recent trends in life expectancy for people with type 1 diabetes in Sweden.

Dennis Petrie, Tom W C Lung, Aidin Rawshani, Andrew J Palmer, Ann-Marie Svensson, Björn Eliasson, Philip Clarke

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Dennis PetrieCentre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Melbourne, VIC, 3053, Australia. dennis.petrie@unimelb.edu.au.ORCID 0000-0002-3882-2531
Tom W C LungCentre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Melbourne, VIC, 3053, Australia.
Aidin RawshaniInstitute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
Andrew J PalmerThe Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Ann-Marie SvenssonInstitute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
Björn EliassonInstitute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
Philip ClarkeCentre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Melbourne, VIC, 3053, Australia.
Sahlgrenska University Hospital · SEThe University of Melbourne · AUThe University of Sydney · AUUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisPeople with type 1 diabetes have reduced life expectancy (LE) compared with the general population. Our aim is to quantify mortality changes from 2002 to 2011 in people with type 1 diabetes in Sweden.

methodsThis study uses health records from the Swedish National Diabetes Register (NDR) linked with death records. Abridged period life tables for those with type 1 diabetes aged 20 years and older were derived for 2002-06 and 2007-11 using Chiang's method. Cox proportional hazard models were used to assess trends in overall and cause-specific mortality.

resultsThere were 27,841 persons aged 20 years and older identified in the NDR as living with type 1 diabetes between 2002 and 2011, contributing 194,685 person-years of follow-up and 2,018 deaths. For men with type 1 diabetes, the remaining LE at age 20 increased significantly from 47.7 (95% CI 46.6, 48.9) in 2002-06 to 49.7 years (95% CI 48.9, 50.6) in 2007-11. For women with type 1 diabetes there was no significant change, with an LE at age 20 of 51.7 years (95% CI 50.3, 53.2) in 2002-06 and 51.9 years (95% CI 50.9, 52.9) in 2007-11. Cardiovascular mortality significantly reduced, with a per year HR of 0.947 (95% CI 0.917, 0.978) for men and 0.952 (95% CI 0.916, 0.989) for women. CONCLUSIONS/

interpretationFrom 2002-06 to 2007-11 the LE at age 20 of Swedes with type 1 diabetes increased by approximately 2 years for men but minimally for women. These recent gains have been driven by reduced cardiovascular mortality.

Indexed as

AdultCardiovascular DiseasesDiabetes Mellitus, Type 1FemaleHumansLife ExpectancyMaleMiddle AgedProportional Hazards ModelsSwedenYoung AdultLife expectancyRelative mortalityType 1 diabetes

Identifiers

PMID27044338
OpenAlexW2314313723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.